Trial NCT04325906, NCT04347941, NCT04358939, NCT04395144
Publication Ehrmann S, Lancet Respir Med, 2021
Primary outcome on the report: Treatment failure within 28 days of enrolment, defined as intubation or death.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.